Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/nroMhMrCCBwwcZQTJD

News for the biotech, medical device, drug and food regulatory profession | December 11, 2008
 
 
Editor's Viewpoint
  • Looking forward to 2009
     
    Ashley McMaster, Lead Editor
    Part I of this FDLI SmartBrief special year-end report looked back at the most important trends and stories of 2008. Part II, below, highlights our predictions and yours -- the FDLI SmartBrief readers -- for what's in store for 2009.

    The upcoming year will present many challenges and opportunities in the food and drug law arena. Companies will work to adjust to the regulatory environment under a new, as-yet-unannounced FDA commissioner, while seeking to renew consumer confidence in drug and food safety. Generic drugs, including follow-on biologics, could gain attention as power in the executive branch transitions from President George W. Bush to President-elect Barack Obama. Also, Congress is expected to begin to examine the possibilities for health care reform, reduction in medical costs and food safety regulations, among other important industry topics.

    As for FDLI events, 2009 will see several significant conferences held in Washington, D.C., including the 2nd Annual Conference on Nanotechnology Law, Regulation & Policy; the 52nd Annual FDLI & FDA Conference; and the 21st Annual Advertising & Promotion Conference. Visit the FDLI Web site for full details.


  Your Predictions 
  • What is the most pressing issue facing the drug industry?
    • Drug safety -- 46%
    • Drug costs -- 22%
    • FDA approval process -- 25%
    • Reimbursement -- 7%
    Email this Story
  • What is the most pressing issue facing the food and ingredients industry?
    • Pathogens in produce and meat -- 39%
    • Imports -- 43%
    • Melamine and other contaminants -- 12%
    • Origin labeling -- 6%
    Email this Story
  • Which legislative/regulatory issue will be most important in 2009?
    • Reimbursement of drugs and devices -- 12%
    • Monitoring of imported drugs and devices -- 39%
    • Drug and device companies' gifts to doctors -- 0%
    • Universal health care -- 49%
    Email this Story
  Upcoming Events 
  • Upcoming FDLI conferences and events
    New Administration Forecast -- Focusing on Food Safety Legislation, Funding, FDA Initiatives and Pending Nutrition Issues
    Dec. 15
    Audioconference

    Pharmaceutical Risk Management: Practical Applications
    Jan. 13, 2009
    Washington, D.C.

    Introduction to Food Law and Regulation
    Jan. 27 to 28, 2009
    Washington, D.C.

    Introduction to Drug Law and Regulation
    Feb. 3 to 4, 2009
    Washington, D.C.

    2nd Annual Conference on Nanotechnology Law, Regulation & Policy
    Feb. 18 to 19, 2009
    Washington, D.C.

    Introduction to Medical Device Law and Regulation
    Feb. 26 to 27, 2009
    Washington, D.C.

    52nd Annual FDLI & FDA Conference
    April 22 to 23, 2009
    Washington, D.C.

    Introduction to Biotechnology Law and Regulation
    May 28 to 29, 2009
    Washington, D.C.

    Introduction to Drug Law and Regulation
    June 25 to 26, 2009
    Washington, D.C.

    21st Annual Advertising & Promotion Conference
    Sept. 22 to 23, 2009
    Washington, D.C.

    Introduction to Drug Law and Regulation
    Nov. 5 to 6, 2009
    Washington, D.C.

    Introduction to Medical Device Law and Regulation
    Nov. 17 to 18, 2009
    Washington, D.C.

    Email this Story
  

Product announcements appearing in SmartBrief are paid advertisements and do not reflect actual FDLI endorsements. The news reported in SmartBrief does not necessarily reflect the official position of FDLI.
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Executive:  Chris Pope 202-737-5500 ext. 295
 
Read more at SmartBrief.com
A powerful Web site for SmartBrief readers including:
 
 
 Recent FDLI SmartBrief Issues:   Lead Editor:  Ashley McMaster
     
Mailing Address:
SmartBrief, Inc.®, 1100 H ST NW, Suite 1000, Washington, DC 20005
 
 
© 1999-2009 SmartBrief, Inc.® Legal Information